U.S. Mortgage REITs Stock News

Immunovant announced six-month off-treatment data from a proof-of-concept study evaluating batoclimab in patients with active Graves' disease, which will be presented at the 2025 Annual Meeting of the American Thyroid Association on September 11. This long-term data highlights potential for batoclimab to manage thyroid hormone levels beyond the treatment period, indicating important clinical progress for the company. We'll explore how this newly released six-month follow-up data shapes...

In the past week, OneMain Holdings, through its subsidiary OneMain Finance Corporation, issued US$800 million in senior notes due 2033 to support general corporate purposes, potentially including debt repurchases or repayments. This move highlights OneMain’s proactive approach to managing its financial structure as it works to maintain flexibility and market positioning. To better understand the implications of this new debt issuance, we'll explore its impact on OneMain Holdings' overall...

If you are tracking Globalstar (GSAT) lately, you have probably noticed the wave of activity sparked by their recent announcement. The company is investing in new gateway infrastructure at OTE S.A.'s commercial teleport in Nemea, Greece, which is just one piece of a global push to upgrade its ground network for the advanced C-3 System. This expansion signals a major commitment to boosting the capabilities of Globalstar's satellite services, aiming to deliver next-generation connectivity to...

If you are wondering what to make of Keurig Dr Pepper (KDP) after its latest move, you are not alone. The company just announced a sweeping new collaboration with Disney Advertising, promising to transform the way fans connect with brands during live sports and across digital platforms. From integrating mixed reality into college football broadcasts to leveraging advanced data-driven insights, this partnership marks a big step forward in how KDP reaches and engages its massive consumer base...

When a company like T. Rowe Price Group (TROW) lands a billion-dollar commitment from Goldman Sachs, people pay attention. The new strategic partnership between these two powerhouses is more than just a handshake. Goldman is putting real money on the table and aiming to own as much as 3.5% of T. Rowe Price via open-market purchases. This direct investment, alongside plans to co-develop retirement and wealth management offerings, is raising eyebrows among investors who have been watching for...

No one likes surprises when it comes to earnings, and PDD Holdings (NasdaqGS:PDD) just delivered a mixed set of results that is sure to get investors talking. The company’s second quarter report showed sales ticking higher compared to last year, but net income drifted lower over both the quarter and the half-year. That kind of split performance creates plenty of debate for anyone deciding what to do next, especially when the share price has been anything but quiet. Since the start of the...

KBR (KBR) has landed in the spotlight after the U.S. Transportation Command terminated the company’s role in the Global Household Goods Contract, a move that sent its shares sliding and triggered a class action investigation. Legal proceedings are now underway, with prominent firms examining whether shareholders were misled about the business impact. The contract’s abrupt loss and the resulting scrutiny are front and center for anyone weighing what comes next for KBR and its stock. This...

If you’re following Crocs (CROX), there’s been quite a bit of leadership news to consider. The company just named Patraic Reagan as its new Chief Financial Officer, stepping in for Susan Healy, who resigned abruptly. Crocs also reaffirmed its financial outlook for the third quarter, signaling a vote of confidence from management as it navigates this executive shakeup. With Reagan’s background at well-known consumer brands like SharkNinja and Nike, investors are likely wondering what his...

Southern (SO) just made a splash with two big announcements that have investors sitting up and taking notice. The company got the green light for five new utility-scale solar projects in Georgia while also raising its five-year base capital plan from $63 billion to $76 billion. Both moves reinforce Southern’s commitment to growing its renewable energy footprint and addressing the Southeast’s soaring electricity demand, especially from data centers and advanced manufacturing. It is a double...

Zillow Group (ZG) has just grabbed attention with a new partnership, this time teaming up with Berkshire Hathaway HomeServices to bring Zillow Showcase, its AI-driven premium listing tool, to a wider network of U.S. agents. The move isn’t just about signing a fresh agreement; it’s about leveraging digital marketing to help listings stand out, sell faster, and fetch higher prices. The latest rollout builds on an earlier collaboration with HomeServices of America, pointing to growing trust in...

If you’ve been watching Agilent Technologies (A) lately, the most recent quarter probably grabbed your attention. The company just posted earnings that came in ahead of forecasts, with both revenue and net income up compared to last year’s third quarter. In addition, Agilent raised its guidance for the rest of fiscal 2025, highlighting stronger than expected business trends and a more confident growth outlook. Investors are now left wondering if this is a signal to reconsider where the...

Amgen (AMGN) just received expanded FDA approval for its cholesterol-lowering drug, Repatha, allowing doctors to prescribe it to an even broader pool of adults at risk for heart disease. Unlike the prior label, which was restricted to people already diagnosed with cardiovascular conditions, the new approval means more patients than ever may now qualify. This is an important shift that could drive commercial uptake in the coming quarters. For investors, this regulatory win is a sizable...

Stoker's, a Turning Point Brands subsidiary, recently launched its Fine Cut Wintergreen in a compact 1.2-ounce can, expanding into 15 states after being available only in 12-ounce tubs. This move not only broadens accessibility and convenience for existing and new customers, but also highlights efforts to diversify and refresh the company's moist smokeless tobacco lineup. We'll explore how expanded product formats and broader retail distribution could strengthen Turning Point Brands' growth...

If you're following Zscaler (ZS), the company just reported its annual and fourth-quarter results, serving up a mix of growing revenue and updated guidance for the year ahead. This type of data-rich announcement often puts the spotlight on what investors should do next, especially when it arrives alongside forward-looking expectations. With revenue for the full year rising compared to last year and management offering a fresh look at what they anticipate next, the conversation now shifts from...

Chemours (NYSE:CC) just made a move that will have shareholders talking at their next check-in. The company’s longtime Chair, Dawn Farrell, has officially stepped down to lead a new Major Projects Office for Canada’s government. In her place, Chemours’ Board tapped independent director Mary Cranston as the new Chair and named Alister Cowan, with a deep financial background, as Lead Independent Director. These appointments are not only about filling seats; they reinforce the Board’s push for...

If you’ve been keeping an eye on lululemon athletica (LULU) lately, you know investors just got a lot to digest. The athletic retailer’s recent earnings revealed that its core U.S. business is under pressure, with sales dipping especially in popular lounge and social product categories. Meanwhile, management pointed to higher tariffs and the removal of the de minimis exemption as key headwinds likely to impact profits in the near term, signaling to the market that cost pressures are climbing...

Kindly MD, Inc. recently announced it has filed for a follow-on equity offering of up to US$5 billion and completed a shelf registration for US$30.39 million, allowing issuance of common and preferred stock, debt securities, warrants, rights, purchase contracts, and units. This dual approach to capital raising expands the company’s financial flexibility, with the at-the-market component and universal shelf registration offering multiple pathways to support potential growth initiatives or...

Innodata (INOD) has just raised eyebrows by lifting its 2025 organic revenue growth forecast to about 45% year over year, up from its previous expectation of 40%. The message from management is clear: demand for its generative AI and Agentic AI services is not just strong, it is accelerating. This move comes on the heels of securing substantial new projects with its largest existing customer as well as adding another major tech company to its roster. These are signals that Innodata’s AI...

Centuri Holdings recently completed a follow-on equity offering, raising US$536.3 million through the sale of over 27 million common shares at US$19.60 each, while also announcing more than US$300 million in new customer awards across the U.S. This dual development highlights Centuri Holdings' expanded access to capital alongside growing demand for its infrastructure and energy solutions among utility clients. We'll explore how the influx of capital from the recent equity offering could...

Flex LNG (NYSE:FLNG) has just reached an important milestone for investors, with its shares now trading ex-dividend after the company declared a USD 0.75 per share payout. This event, while anticipated by those following the company’s dividend schedule, often triggers reactions among traders looking to capture or reposition around dividend payments. The move signals Flex LNG’s ongoing commitment to returning capital to its shareholders, and it could reshape short-term sentiment as markets...

AppLovin, Robinhood, and EMCOR Group have been announced as additions to the S&P 500 Index following the latest quarterly review, effective September 22, 2025. This inclusion often leads to increased demand from index-tracking funds and ETFs, potentially driving greater investor interest in EMCOR Group ahead of the rebalancing date. We'll now look at how S&P 500 inclusion may influence EMCOR Group’s position within its sector and future growth outlook. Explore 23 top quantum computing...

Carvana (CVNA) is turning heads once again, as its shares have continued to make waves in the market. For investors wondering what to do next, the past month’s movement might feel like a crossroads. Is the volatility a signal, or just noise in a sector known for its ups and downs? Nothing in particular has triggered the latest round of trading, yet the company’s steady presence near new highs is prompting plenty of conversations among market-watchers. Momentum has been building for Carvana,...

If you are wondering what to make of the recent headlines about Eli Lilly (LLY), you are not alone. The company just scored an FDA Breakthrough Therapy designation for its lung cancer drug olomorasib in combination with pembrolizumab, signaling strong regulatory momentum in oncology. On top of that, Lilly announced encouraging Phase 3 results for orforglipron, its oral GLP-1 candidate for obesity and type 2 diabetes, a space that continues to capture investor attention. These late-stage...

If you have been keeping an eye on Arcutis Biotherapeutics (ARQT), you probably noticed the buzz following their recent news. The company just announced the submission of a supplemental New Drug Application to the FDA, aiming to expand the use of ZORYVE cream 0.3% for plaque psoriasis in children as young as two years old. If regulators give the green light, ZORYVE would stand alone as the only topical PDE4 inhibitor approved for this young patient group. This move could carve out a larger...